ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,348, issued on July 8, was assigned to AVVINITY THERAPEUTICS Ltd. (GB/GB) (London).
"Compounds and therapeutic uses thereof" was invented by Melanie Glossop (Sandwich, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of the compounds in treating cancer and infectious diseases, to compositions containing the compounds, processes for their preparation and to novel intermediates used in the process."
The patent was filed on Oct. 10, 2019, under Application No. 17/284,379.
*For further information, including image...